Jie Ji

1.5k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Jie Ji is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Jie Ji has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Jie Ji's work include RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jie Ji is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jie Ji collaborates with scholars based in China, United States and Germany. Jie Ji's co-authors include Runqiu Jiang, Junwei Tang, Beicheng Sun, Chuanyong Guo, Liwei Wu, Jiao Feng, Weiqi Dai, Jianye Wu, Jie Zhang and Jingjing Li and has published in prestigious journals such as Nature Communications, Free Radical Biology and Medicine and Medicine.

In The Last Decade

Jie Ji

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis

2023 107 citations Yan Li, Wenjuan Yang et al. Journal of Experimental & Clinical Cancer Research profile →

Peers

Countries citing papers authored by Jie Ji

Since Specialization

Citations

This map shows the geographic impact of Jie Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ji more than expected).

Fields of papers citing papers by Jie Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ji. The network helps show where Jie Ji may publish in the future.

Co-authorship network of co-authors of Jie Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ji. A scholar is included among the top collaborators of Jie Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ji. Jie Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PSPH promotes colorectal cancer growth by triggering autophagy through AMPK-ULK1 activation and enhancing tumor immune evasion 2025 ·General Physiology and Biophysics ·(unknown), Jie Ji, (unknown), Jianhua Fu, (unknown), (unknown)	0
2	TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system 2024 ·Free Radical Biology and Medicine ·Jie Zhang, (unknown), Ziqi Cheng, Jie Ji, Liwei Wu, Jiao Feng, (unknown), Jianye Wu, Chuanyong Guo	6
3	Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction 2023 ·Frontiers in Pharmacology ·Yuanyuan Zheng, Wenjuan Yang, Yewei Jia, Jie Ji, Liwei Wu, Jiao Feng, Yan Li, (unknown), Jie Zhang, Jingjing Li, Weiqi Dai, (unknown), Jianye Wu, Yingqun Zhou, Chuanyong Guo	4
4	Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis breakdown → 2023 ·Journal of Experimental & Clinical Cancer Research ·Yan Li, Wenjuan Yang, Yuanyuan Zheng, Weiqi Dai, Jie Ji, Liwei Wu, Ziqi Cheng, Jie Zhang, Jingjing Li, (unknown), Jianye Wu, Mingwei Yang, Jiao Feng, Chuanyong Guo	107
5	Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer 2023 ·Medicine ·(unknown), Yanhui Zhu, Jie Ji	3
6	Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway 2022 ·Journal of Cellular and Molecular Medicine ·Qiang Yu, Weiqi Dai, Jie Ji, Liwei Wu, Jiao Feng, Jingjing Li, Yuanyuan Zheng, (unknown), Ziqi Cheng, Jie Zhang, Jianye Wu, (unknown), Chuanyong Guo	37
7	Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4 2022 ·Journal of Oncology ·Han Zhuo, Shuying Miao, (unknown), Deming Zhu, (unknown), (unknown), Jie Ji, Zhongming Tan	4
8	Correction to: Current status of ctDNA in precision oncology for hepatocellular carcinoma 2021 ·Journal of Experimental & Clinical Cancer Research ·Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu, Chuanyong Guo	3
9	<p>Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2</p> 2020 ·Journal of Hepatocellular Carcinoma ·Tong Liu, Sainan Li, Liwei Wu, Qiang Yu, Jingjing Li, Jiao Feng, (unknown), Jiaojiao Chen, (unknown), Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu, Chuanyong Guo	49
10	Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis 2020 ·Journal of Experimental & Clinical Cancer Research ·Jiao Feng, Weiqi Dai, Yuqing Mao, Liwei Wu, Jingjing Li, Kan Chen, Qiang Yu, Rui Kong, Sainan Li, Jie Zhang, Jie Ji, Jianye Wu, Wenhui Mo, Xuanfu Xu, Chuanyong Guo	169
11	Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy 2019 ·Mediators of Inflammation ·Wenwen Wang, Liwei Wu, Jingjing Li, Jie Ji, Kan Chen, Qiang Yu, Sainan Li, Jiao Feng, Tong Liu, Jie Zhang, Jiaojiao Chen, (unknown), Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Chuanyong Guo, Jianye Wu	39
12	PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma 2019 ·Journal of Experimental & Clinical Cancer Research ·Jiao Feng, Liwei Wu, Jie Ji, Kan Chen, Qiang Yu, Jie Zhang, Jiaojiao Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Ling Xu, Jianye Wu, Chuanyong Guo	80
13	Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis 2019 ·Journal of Cellular and Molecular Medicine ·Jiao Feng, Chengfen Wang, Tong Liu, Jingjing Li, Liwei Wu, Qiang Yu, Sainan Li, Yuting Zhou, Jie Zhang, (unknown), Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu, Chuanyong Guo	56
14	The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion 2017 ·Nature Communications ·Runqiu Jiang, Junwei Tang, Yun Chen, Lei Deng, Jie Ji, Yu Xie, Ke Wang, Wei Jia, Wen‐Ming Chu, Beicheng Sun	288
15	HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma 2015 ·Cellular Physiology and Biochemistry ·Jun Li, Xiaochen Wang, Junwei Tang, Runqiu Jiang, Wenjie Zhang, Jie Ji, Beicheng Sun	189
16	Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma. 2015 ·PubMed ·Qing Li, Xin Zeng, Cheng Xue, Jingmin Zhang, Jie Ji, Jinsong Wang, (unknown), Qiong Qi, Wenbin Huang	14
17	The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma 2015 ·International Journal of Gynecological Pathology ·Qing Li, Cheng Xue, Jie Ji, Jingmin Zhang, Wenbin Huang	18
18	MicroRNA‐191, by promoting the EMT and increasing CSC‐like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells 2014 ·Molecular Carcinogenesis ·Wenchao Xu, Jie Ji, Yue Xu, Yawei Liu, Le Shi, Yi Liu, Xiaolin Lü, Yue Zhao, Fei Luo, Bairu Wang, Rongrong Jiang, Jianping Zhang, Qizhan Liu	73
19	The fractional variational iteration method improved with the Adomian series 2012 ·Applied Mathematics Letters ·Jie Ji, Jian‐bing Zhang, (unknown)	13
20	Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma 2012 ·European Journal of Gastroenterology & Hepatology ·Xiaodan Huang, Jie Ji, Huiting Xue, Faming Zhang, Xiang Han, Yong Cai, Jianhuai Zhang, Guozhong Ji	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact